Total Visits
| Views | |
|---|---|
| Molecular ... | 25 |
Total Visits Per Month
| March 2022 | April 2022 | May 2022 | June 2022 | July 2022 | August 2022 | September 2022 | |
|---|---|---|---|---|---|---|---|
| Molecular ... | 1 | 3 | 0 | 0 | 0 | 0 | 0 |
File Visits
| Views | |
|---|---|
| molecular_clinical_determinants_response_resistance_rucaparib_recurrent_ovarian_cancer_treatment_ariel2_parts_1_2_2021.pdf | 91 |
| molecular_clinical_determinants_response_resistance_rucaparib_recurrent_ovarian_cancer_treatment_ariel2_parts_1_2_2021_material_suplementari1.pdf | 18 |
| molecular_clinical_determinants_response_resistance_rucaparib_recurrent_ovarian_cancer_treatment_ariel2_parts_1_2_2021_material_suplementari2.pdf | 4 |
Top country views
| Views | |
|---|---|
| United States | 14 |
| Spain | 4 |
| Germany | 2 |
| France | 2 |
| Belgium | 1 |
| Finland | 1 |
| Sweden | 1 |
Top cities views
| Views | |
|---|---|
| Ashburn | 3 |
| Barcelona | 2 |
| Phoenix | 2 |
| Brussels | 1 |
| Cheyenne | 1 |
| Chicago | 1 |
| Helsinki | 1 |
| Madrid | 1 |
| San Antonio | 1 |
| Washington | 1 |